Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Polynucleotides and fish allergy
Intimate polynucleotides are non-hormonal biostimulatory treatments used in some clinics for vulvovaginal tissue quality. The key decision is whether the symptom has been properly assessed first.
Direct answer
A severe fish or seafood allergy is usually a reason to avoid fish-derived polynucleotide treatment, particularly if there has been anaphylaxis. Although purification removes much of the protein material that drives allergy, this does not make the treatment risk-free. Mild sensitivity may need individual assessment, product checking and sometimes patch testing. Any swelling of the lips or tongue, breathing difficulty, widespread hives or faintness needs urgent help.
The safest plan starts by clarifying the symptom, checking red flags, explaining alternatives and agreeing realistic expectations before any procedure is booked.
Educational only. Suitability must be confirmed after consultation and assessment. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
Polynucleotides at a glance
Non-hormonal biostimulation
Key point 1
Polynucleotides (such as Plinest or Ameela) are derived from highly purified salmon or trout DNA.
Key point 2
The extensive manufacturing process strips away allergenic proteins and lipids, leaving essentially pure nucleotide chains.
Key point 3
Used as a regenerative adjunct treatment for vulval Lichen Sclerosus, vaginal atrophy, and intimate tissue hydration.
Key point 4
The risk of an allergic reaction is low due to the product's high purity, but the potential for hypersensitivity.
Important safety note
A history of severe fish or seafood allergy, especially a history of anaphylaxis, prevents treatment.
Allergy
Technique
Timeline
Aftercare
Detailed answer
How polynucleotides fit into intimate care
Polynucleotides are best explained as biostimulatory DNA fragments rather than fillers. The clinical question is whether they match the diagnosis, tissue findings and safety profile.
Not a standard filler
The aim is gradual tissue-quality support through repair signalling, hydration and extracellular-matrix activity, not instant volume or a promised sexual-function outcome.
Evidence
Symptoms
Alternatives
What it means
Many aesthetic doctors and dermatologists report zero instances of allergic reactions in their clinics, even among patients with mild fish allergies.
Why it happens
This is largely because there is no actual fish protein or tissue in the final pharmaceutical-grade injectable.
Evidence limits
Despite the rarity of reactions, responsible doctor-led clinics maintain strict protocols prioritizing patient safety, treating severe fish allergy as an absolute barrier to treatment to completely mitigate anaphylactic risk.
Treatment fit
For patients with mild or uncertain fish sensitivities, clinicians may perform a patch test by placing a small amount of the product on the forearm and observing the patient in-clinic.
What this means in practice
For patients with mild or uncertain fish sensitivities, clinicians may perform a patch test by placing a small amount of the product on the forearm and observing the patient in-clinic for an hour.
A full treatment course typically requires 2 to 4 sessions spaced 3 to 4 weeks apart.
Patient safety
Why diagnosis comes first
Dryness, soreness, tearing or painful sex may reflect GSM, infection, dermatoses, pelvic-floor guarding or medication effects, so the treatment choice depends on assessment.
It checks the cause
Many aesthetic doctors and dermatologists report zero instances of allergic reactions in their clinics, even among patients with mild fish allergies.
It protects safety
A history of severe fish or seafood allergy, especially a history of anaphylaxis, prevents treatment.
It reviews alternatives
For patients with mild or uncertain fish sensitivities, clinicians may perform a patch test by placing a small amount of the product on the.
It sets expectations
A full treatment course typically requires 2 to 4 sessions spaced 3 to 4 weeks apart.
Non-hormonal does not mean automatic
A hormone-free treatment may still be unsuitable if there is active infection, unexplained bleeding, pregnancy, recent surgery, severe fish allergy or unclear pelvic pain.
The consultation should cover product source, allergy risk, alternatives such as moisturisers or local hormonal care, and realistic timelines for tissue response.
Considerations
What to consider
For patients with mild or uncertain fish sensitivities, clinicians may perform a patch test by placing a small amount of the product on the forearm and observing the patient in-clinic for an hour.
Consultation priorities
A detailed medical history review is conducted, focusing specifically on the severity and nature of the patient's fish/seafood allergy.
Consent
Aftercare
Follow-up
Before treatment
A detailed medical history review is conducted, focusing specifically on the severity and nature of the patient's fish/seafood allergy.
During care
The clinician decides if a patch test is appropriate or if the treatment must be entirely declined for safety reasons.
Aftercare
A forearm patch test is conducted; if the skin remains clear after an hour, the full intimate treatment can be scheduled for a subsequent day.
When to reassess
Multiple micro-injections are administered to the intimate area (e.g., vulval tissue) after applying a topical numbing cream to ensure patient comfort.
Practical expectations
A full treatment course typically requires 2 to 4 sessions spaced 3 to 4 weeks apart.
Patients must fully and honestly disclose all dietary and medical allergies, as well as current medications, during the consultation.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: polynucleotides are fillers
Reality: they are biostimulatory DNA fragments, usually used for gradual tissue-quality support rather than volume.
Myth: hormone-free means suitable for everyone
Reality: allergy, infection, bleeding, pregnancy, recent surgery and unexplained pain can still make treatment unsuitable.
Myth: hydration means instant repair
Reality: hydration may be noticed earlier, but collagen and tissue-quality changes are gradual and variable.
Evidence and limits
Mechanism-of-action language should not be treated as proof of a predictable clinical result.
Alternatives still matter
Moisturisers, local hormonal care, pelvic-floor physiotherapy, infection treatment or specialist review may be more appropriate for some patients.
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
Do not claim intimate polynucleotides cure dryness, laxity, sexual dysfunction, pelvic symptoms, scarring or menopause-related tissue change. Explain that PN products are often fish/marine-derived and allergy history matters.
Are alternatives clear?
For patients with mild or uncertain fish sensitivities, clinicians may perform a patch test by placing a small amount of the product on the forearm and observing.
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
Pause treatment for active infection, unexplained bleeding, severe fish allergy, pregnancy, recent pelvic surgery or severe pain that has not been assessed.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Allergy symptoms
Swelling of the lips or tongue, breathing difficulty, widespread hives, faintness or collapse after exposure needs urgent medical help.
Bleeding or infection
New post-menopausal bleeding, unusual discharge, fever, pelvic pain, thrush, BV or UTI symptoms should be assessed before injectable treatment.
Infection signs
Fever, spreading redness, pus or feeling unwell after a procedure needs urgent advice.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
Regulatory resources
Authoritative resources
These sources support cautious, assessment-led patient information and help separate clinical evidence from promotional claims.
PubMed: PN/HA intradermal injections for vulvovaginal atrophy
This pilot study is directly relevant to polynucleotide and hyaluronic acid use in vulvovaginal atrophy.
Real-world study of polynucleotide-based vaginal ovules
This source supports cautious discussion of PN-based vaginal ovules, hydration and atrophy-related symptoms.
NHS guidance on allergies
NHS allergy guidance supports screening and urgent escalation language for fish-derived products.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes, risks and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 59 imported records. Additional reviewed material included clinical papers, guidance documents and patient-facing medical resources; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.
